Hostname: page-component-8448b6f56d-mp689 Total loading time: 0 Render date: 2024-04-25T00:19:40.968Z Has data issue: false hasContentIssue false
  • English
  • Français

Bias in Uncontrolled Brain Tumor Trials

Published online by Cambridge University Press:  18 September 2015

William R. Shapiro
William R. Shapiro*
Affiliation:
Phoenix, Arizona, USA
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorials
Information
Canadian Journal of Neurological Sciences , Volume 24 , Issue 4 , November 1997 , pp. 269 - 270
Copyright
Copyright © Canadian Neurological Sciences Federation 1997

References

REFERENCES

1.Shapiro, WR, Shapiro, JR, Walker, RW. Management of specific malignancies: Central nervous system. In: Abeloff, MD, Armitage, JO, Lichter, AS, Niederhuber, JE, eds. Clinical Oncology. New York: Churchill Livingston, 1995: 851–912.Google Scholar
2.Winger, MJ, Macdonald, DR, Schold, SC Jr, Cairncross, JG. Selection bias in clinical trials of anaplastic glioma. Ann Neurol 1989; 26: 531–534.CrossRefGoogle ScholarPubMed
3.Florell, RC, Macdonald, DR, Irish, WD, et al. Selection bias, survival, and brachytherapy for glioma. J Neurosurg 1992; 76: 179–183.CrossRefGoogle ScholarPubMed
4.Irish, WD, Macdonald, DR, Cairncross, JG. Measuring bias in uncontrolled brain tumor trials: to randomize or not to randomize? Can J Neurol Sci 1997; 24: 307.CrossRefGoogle ScholarPubMed
5.Loeffler, JS, Alexander, E III, Shea, WM, et al. Radiosurgery as part of the initial management of patients with malignant gliomas. J Clin Oncol 1992; 10: 1379–1385.CrossRefGoogle ScholarPubMed
6.Loeffler, JS, Shrieve, DC, Wen, PY, et al. Radiosurgery for intracranial malignancies. Sem Radiat Oncol 1995; 3: 225–234.CrossRefGoogle Scholar
7.Loeffler, JS, Shrieve, DC, Alexander, E III. Radiosurgery for glioblastoma multiforme: the importance of selection criteria. Int J Radiat Oncol Biol Phys 1994; 30: 731–733.CrossRefGoogle ScholarPubMed
8.Mahaley, MS. Neuro-oncology index and review (adult primary brain tumors). Radiotherapy, chemotherapy, immunotherapy, photodynamic therapy. J Neurooncol 1991; 11: 85–147.CrossRefGoogle ScholarPubMed
9.Green, SB, Byar, DP, Walker, MD, et al. Comparisons of carmustine, procarbazine and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep 1983; 67: 121–132. Google ScholarPubMed
10.Levin, VA, Wara, WM, Davis, RL, et al. Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydorxyurea for malignant gliomas. J Neurosurg 1985; 63: 218–223.CrossRefGoogle ScholarPubMed
11.Levin, VA, Silver, P, Hannigan, J, et al. Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report. Int J Radiat Oncol Biol Phys 1990; 18: 321–324.CrossRefGoogle ScholarPubMed
12.Prados, MD, Gutin, PH, Phillips, TL, et al. Interstitial brachytherapy for newly diagnosed patients with malignant gliomas: the UCSF experience. Int J Radiat Oncol Biol Phys 1992; 24: 593–597.CrossRefGoogle ScholarPubMed
13.Shapiro, WR, Green, SB, Burger, P, et al. A randomized trial of interstitial radiotherapy (IRT) boost for the treatment of newly diagnosed malignant glioma (glioblastoma multiforme, anaplastic astrocytoma, anaplastic oligodendroglioma, malignant mixed glioma): BTCG study 8701. Neurology 1994; 44 (Suppl 2): 263(Abstract).Google Scholar
14.Edwards, MSB, Wara, WM, Urtasun, RC, et al. Hyperfractionated radiation for brain-stem glioma: a Phase I-II trial. J Neurosurg 1989; 70: 691–700.CrossRefGoogle ScholarPubMed
15.Packer, RJ, Boyett, JM, Zimmerman, RA, et al. Hyperfractionated radiation therapy (72 Gy) for children with brain stem gliomas: a Childrens Cancer Group phase I/II Trial. Cancer 1993; 72: 1414–1421.3.0.CO;2-C>CrossRefGoogle ScholarPubMed
16.Freeman, CR, Krischer, JP, Sanford, RA, et al. Final results of a study of escalating doses of hyperfractionated radiotherapy in brain stem tumors in children: a Pediatric Oncology Group study. Int J Radiat Oncol Biol Phys 1993; 27: 197–206.CrossRefGoogle ScholarPubMed
17.Packer, RJ, Boyett, JM, Zimmerman, RA, et al. Outcome of children with brain stem gliomas after treatment with 7800 cGy of hyperfractionated radiotherapy: a Childrens Cancer Group Phase I/II Trial. Cancer 1994; 74: 1827–1834.3.0.CO;2-Q>CrossRefGoogle ScholarPubMed
18.Shapiro, WR, Green, SB, Burger, PC, et al. A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma. J Neurosurg 1992; 76: 772–781.CrossRefGoogle ScholarPubMed